Chronic Pseudomonas aeruginosa biofilm infection impairs murine S100A8/A9 and neutrophil effector cytokines-implications for delayed wound closure?
暂无分享,去创建一个
N. Høiby | C. Moser | P. Jensen | H. Trøstrup | C. Lerche | L. Christophersen | K. Thomsen | H. Hougen | P. Ø. Jensen
[1] N. Høiby,et al. Biofilms and host response – helpful or harmful , 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[2] A. Schmidtchen,et al. Pseudomonas aeruginosa elastase cleaves a C-terminal peptide from human thrombin that inhibits host inflammatory responses , 2016, Nature Communications.
[3] N. Høiby,et al. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus , 2016, Archives of Dermatological Research.
[4] Hans C. Bernstein,et al. Microsensor and transcriptomic signatures of oxygen depletion in biofilms associated with chronic wounds , 2016, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[5] Benjamin A Lipsky,et al. Biofilms and Wounds: An Overview of the Evidence. , 2015, Advances in wound care.
[6] N. Høiby,et al. Bactericidal effect of colistin on planktonic Pseudomonas aeruginosa is independent of hydroxyl radical formation. , 2014, International journal of antimicrobial agents.
[7] Raquel Navarro,et al. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. , 2013, Immunity.
[8] P. Stewart,et al. Biofilms and Inflammation in Chronic Wounds. , 2013, Advances in wound care.
[9] N. Høiby,et al. Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound model , 2013, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[10] T. Standiford,et al. Genome-wide transcriptional analysis of differentially expressed genes in flagellin-pretreated mouse corneal epithelial cells in response to Pseudomonas aeruginosa: involvement of S100A8/A9 , 2013, Mucosal Immunology.
[11] N. Høiby,et al. Bead‐size directed distribution of Pseudomonas aeruginosa results in distinct inflammatory response in a mouse model of chronic lung infection , 2012, Clinical and experimental immunology.
[12] David W Williams,et al. A review of the scientific evidence for biofilms in wounds , 2012, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[13] K. Tracey,et al. Alarmins: awaiting a clinical response. , 2012, The Journal of clinical investigation.
[14] R. Gallo,et al. Antimicrobial peptides: Old Molecules with New Ideas , 2011, The Journal of investigative dermatology.
[15] L. Jørgensen,et al. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling , 2011, The British journal of dermatology.
[16] T. Bjarnsholt,et al. Success Rate of Split-Thickness Skin Grafting of Chronic Venous Leg Ulcers Depends on the Presence of Pseudomonas aeruginosa: A Retrospective Study , 2011, PloS one.
[17] A. Chang,et al. A Comparison of Wound Area Measurement Techniques: Visitrak Versus Photography , 2011, Eplasty.
[18] M. Mildner,et al. The antimicrobial heterodimer S100A8/S100A9 (calprotectin) is upregulated by bacterial flagellin in human epidermal keratinocytes. , 2010, The Journal of investigative dermatology.
[19] K. Harding,et al. Non-healing is associated with persistent stimulation of the innate immune response in chronic venous leg ulcers. , 2010, Journal of dermatological science.
[20] F. Gottrup,et al. Cost of wound treatment to increase significantly in Denmark over the next decade. , 2010, Journal of wound care.
[21] T. Tolker-Nielsen,et al. Nonrandom Distribution of Pseudomonas aeruginosa and Staphylococcus aureus in Chronic Wounds , 2009, Journal of Clinical Microbiology.
[22] G. Jacobsen,et al. Thermal injury induces impaired function in polymorphonuclear neutrophil granulocytes and reduced control of burn wound infection , 2009, Clinical and experimental immunology.
[23] M. Herzberg,et al. Calprotectin S100A9 Calcium-binding Loops I and II Are Essential for Keratinocyte Resistance to Bacterial Invasion* , 2009, Journal of Biological Chemistry.
[24] R. Gallo,et al. Antimicrobial peptides, skin infections, and atopic dermatitis. , 2008, Seminars in cutaneous medicine and surgery.
[25] T. Tolker-Nielsen,et al. Distribution, Organization, and Ecology of Bacteria in Chronic Wounds , 2008, Journal of Clinical Microbiology.
[26] Eric P. Skaar,et al. Metal Chelation and Inhibition of Bacterial Growth in Tissue Abscesses , 2008, Science.
[27] P. Williams,et al. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. , 2007, Microbiology.
[28] T. Krieg,et al. Inflammation in wound repair: molecular and cellular mechanisms. , 2007, The Journal of investigative dermatology.
[29] D. Hassett,et al. The Exopolysaccharide Alginate Protects Pseudomonas aeruginosa Biofilm Bacteria from IFN-γ-Mediated Macrophage Killing1 , 2005, The Journal of Immunology.
[30] A. Kharazmi,et al. Faster activation of polymorphonuclear neutrophils in resistant mice during early innate response to Pseudomonas aeruginosa lung infection , 2004, Clinical and experimental immunology.
[31] J. Davidson,et al. Migration inhibitory factor‐related protein (MRP)8 and MRP14 are differentially expressed in free‐electron laser and scalpel incisions , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[32] A. Jesaitis,et al. Compromised Host Defense on Pseudomonas aeruginosa Biofilms: Characterization of Neutrophil and Biofilm Interactions 1 , 2003, The Journal of Immunology.
[33] C. Moser,et al. Cytokine and surface receptor diversity of NK cells in resistant C3H/HeN and susceptible BALB/c mice with chronic Pseudomonas aeruginosa lung infection , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[34] S. Werner,et al. Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.
[35] I. Thorey,et al. The Ca2+-binding Proteins S100A8 and S100A9 Are Encoded by Novel Injury-regulated Genes* , 2001, The Journal of Biological Chemistry.
[36] M. Herzberg,et al. Calprotectin Expression In Vitro by Oral Epithelial Cells Confers Resistance to Infection by Porphyromonas gingivalis , 2001, Infection and Immunity.
[37] Shizhong Xu,et al. Genetic control of the rate of wound healing in mice , 2001, Heredity.
[38] M. Herzberg,et al. Calprotectin Expression Inhibits Bacterial Binding to Mucosal Epithelial Cells , 2001, Infection and Immunity.
[39] W. Payne,et al. Maintenance of wound bacterial balance. , 1999, American journal of surgery.
[40] A. Kharazmi,et al. Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T‐helper cell response , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[41] J. Rygaard,et al. Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[42] M. Robson,et al. Wound Infection: A Failure of Wound Healing Caused by an Imbalance of Bacteria , 1997 .
[43] S. Cryz,et al. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle. , 1997, Behring Institute Mitteilungen.
[44] J. Rygaard,et al. Interferon‐gamma (IFN‐γ) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats , 1996, Clinical and experimental immunology.
[45] J. Rygaard,et al. Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection , 1994, Infection and immunity.
[46] T. Theander,et al. Dichotomy of the human T cell response to Leishmania antigens. I. Th1‐like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis , 1994, Clinical and experimental immunology.
[47] G. Pier,et al. Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments , 1993, Infection and immunity.
[48] A. Kharazmi,et al. Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa. , 1991, Immunology letters.
[49] E. Lingaas,et al. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin , 1990, The Lancet.
[50] M. Röllinghoff,et al. IL-1 beta is secreted by activated murine macrophages as biologically inactive precursor. , 1990, Journal of immunology.
[51] P. Brandtzaeg,et al. Epidermal and dermal distribution of a myelomonocytic antigen (L1) shared by epithelial cells in various inflammatory skin diseases. , 1986, Journal of the American Academy of Dermatology.
[52] J. Albina,et al. Wound macrophages as key regulators of repair: origin, phenotype, and function. , 2011, The American journal of pathology.
[53] K. Krogfelt,et al. Why chronic wounds will not heal: a novel hypothesis , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.